THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha® (evolucumab).
News Stories
Name: NLA News
THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S.
Name: NLA News
The National Lipid Association (NLA) and Foundation of the National Lipid Association (FNLA) Urge CMS and Administrator Oz to Include Low-Density Lipoprotein Cholesterol (LDL-C) Measurement in CMS Quality Measurement Programs
NEWS PROVIDED BY
National Lipid Association
May 19, 2025, 10:07 AM ET
Name: NLA News


.png)







